For COVID-19 patients, the septic shock inpatient mortality was 59.4 percent, while it was nearly 32 percent for influenza patients. Additionally, those with COVID-19 faced a significantly higher overall inpatient mortality rate — nearly 16 percent compared to 4.1 percent of hospitalized influenza patients.
Researchers evaluated data from 66,236 hospitalized COVID-19 patients and compared it to data from 56,896 hospitalized influenza patients during the flu seasons of 2016-18. Data was compiled from 83 healthcare organizations throughout the country, representing 358 hospitals.
The findings indicate that physicians should be vigilant when monitoring for sepsis in COVID-19 patients, and call for additional research to better understand how the condition develops in coronavirus patients, the study concludes.
More articles on infection control:
Vermont hospital to close OR after staff mysteriously fall ill again; won’t reopen until cause is found
Washington hospital battles 2nd COVID-19 outbreak
Half of isolation gowns from global suppliers don’t meet US standards, report finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
